Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia

Journal of Human Genetics

Volumn 51, Issue 9, 2006, Pages 832-838

  Chim, C S ^b   Fung, T K ^b   Wong, K F ^a   Lau, J S ^a   Liang, R ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apaf 1; Chinese; CLL; DAP kinase; Methylation; P14

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEATH ASSOCIATED PROTEIN KINASE; DEXAMETHASONE; FLUDARABINE; MITOXANTRONE; PREDNISOLONE; PROCARBAZINE; PROTEIN P14; PROTEIN P53; VINCRISTINE;

ADULT; AGED; ALLELE; ARTICLE; BONE MARROW; CANCER SURVIVAL; CAUCASIAN; CHINESE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN METHYLATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASE-CONTROL STUDIES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33748657136     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-006-0029-x     Document Type: Article

References (32)

1. Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, Lam WK, Kwong YL (2002) Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Clin Cancer Res 8:3741-3746
2. Chim CS, Tam CY, Liang R, Kwong YL (2001a) Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer 91:2222-2229
3. Chim CS, Liang R, Tam C, Kwong YL (2001b) p15 and P16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 19:2033-2040
4. Chim CS, Liang R, Kwong YL (2002) Gene promoter hypermethylation in hematologic malignancies. Hematol Oncol 20: 167-176
5. Chim CS, Fung TK, Cheung J, Liang R Kwong YL (2004a) SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Blood 103:4630-4635
6. Chim CS, Kwong YL, Fung TK, Liang R (2004b) Methylation profiling in multiple myeloma. Leuk Res 28:379-385
7. Chim CS, Fung TK, Wong KF, Lau JS, Law M, Liang R (2005a) Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor (CKI) in chronic lymphocytic leukemia (CLL) in Chinese. J Clin Pathol (in press)
8. Chim CS, Wong AS, Pang A, Chu P, Lau JS, Wong KF, Kwong YL (2005b) Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia (in press)
9. Chim CS, Fung TK, Wong KF, Lau JS, Liang R (2006) Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in Chronic Lymphocytic Leukemia. Leukemia Res (in press)
10. Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2003) Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 17:1813-1819
11. Drexler HG (1998) Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leuKemia-lymphoma cells. Leukemia 12:845-859
12. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG (2000) Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60:129-133
13. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancers. Can Res 61:3225-3229
14. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-6
15. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054
16. Juliusson G, Merup M (1998) Cytogenetics in chronic lymphocytic leukemia. Semin Oncol 25:19-26
17. Katzenellenbogen RA, Baylin SB, Herman JG (1999) Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93:4347-4353
18. Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kipps TJ (2003) Biology and treatment of chronic lymphocytic leukemia. In Hematology (Am Soc Hematol Educ Program). pp 153-175
19. Kwong YL, Wong KF, Chan LC, Liang RHS, Chan JKC, Wei D, Chiu EKW, Chan CH, Todd D, Chan TK (1994) The spectrum of chronic lymphoproliferative disorders in Chinese people: an analysis of 64 cases. Cancer 74:174-181
20. Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression. Nature 432:307-315
21. Ma SY, Au WY, Chim CS, Lie AK, Lam CC, Tse E, Leung AY, Liang R, Kwong YL (2004) Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. Br J Haematol 124:754-761
22. Muller-Hermelink HK, Catovsky D, Monstserrat E, Harris NL (2001) Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of the haematopoietic and lymphoid tissues world health organization classification of tumours, International Agency for Research on Cancer, Lyon pp 127-130
23. Nagy E, Beck Z, Kiss A, Csoma E, Telek B, Konya J, Olah E, Rak K, Toth FD (2003) Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase. Eur J Cancer 39:2298-2305
24. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. Ca Cancer J Clin 47:5-27
25. Peller S, Rotter V (2003) TP53 in hematological cancer: low incidence of mutations with significant clinical relevance. Hum Mutat 21:277-284
26. Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A (2001) DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 3:1-7
27. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz MJ, Prosper F, Heiniger A, Torres A (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104:2492-2498
28. Sherr CJ (2001) The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2:731-737
29. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207-211
30. Taniguchi T, Chikatsu N, Takahashi S, Fujita A, Uchimaru K, Asano S, Fujita T, Motokura T (1999) Expression of p16INK4A and p14ARF in hematological malignancies. Leukemia 13:1760-1769
31. Winkler D, Schneider C, Kröber A, Pasqualucci L, Lichter P, Döhner H, Stilgenbauer S (2005) Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). Leukemia 19:1211-1215
32. Wong KF, Chan JKC (1999) Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese. Cancer Genet Cytogenet 111:55-60